Citation 149034

JENNINGS,KR: STARRATT,AN: PENARANDA,P: LOUGHTON,BG:. (1999). PHARMACOLOGICAL STUDIES OF DELPHINIUM ALKALOIDS AT THE NICOTINIC ACETYLCHOLINE RECEPTOR.. 232()

Citation Details

Title	PHARMACOLOGICAL STUDIES OF DELPHINIUM ALKALOIDS AT THE NICOTINIC ACETYLCHOLINE RECEPTOR.
Authors	JENNINGS,KR: STARRATT,AN: PENARANDA,P: LOUGHTON,BG:
Year	1999
Volume	232
Issue

Summary

Year: 1999

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	ACONITINE	.
2	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	ACONITINE	ACTIVE
3	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	DELPHININE	.
4	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DELPHININE	INACTIVE
5	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	NUDICAULINE	.
6	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NUDICAULINE	ACTIVE
7	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	LYCACONITINE	.
8	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCACONITINE	ACTIVE
9	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	DELSEMINE	.
10	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	DELSEMINE	ACTIVE
11	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	LYCOCTONINE,ANTHRANOYL:	.
12	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCOCTONINE,ANTHRANOYL:	ACTIVE
13	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	CONDELPHINE	.
14	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CONDELPHINE	ACTIVE
15	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	KARACOLINE	.
16	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	KARACOLINE	ACTIVE
17	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	LYCOCTONINE	.
18	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCOCTONINE	ACTIVE
19	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	NICOTINE	ACTIVE
20	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	CORRECTION OF STRUCTURE	NICOTINE	ACTIVE
21	TOXICITY ASSESSMENT(QUANTITATIVE)	PHARMACOLOGY OF COMPOUND - IN VIVO	LYCACONITINE,METHYL:	.
22	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCACONITINE,METHYL:	ACTIVE
23	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	CORRECTION OF STRUCTURE	LYCACONITINE,METHYL:	ACTIVE
24	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCACONITINE,DEHYDRO: METHYL:	ACTIVE
25	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	CORRECTION OF STRUCTURE	LYCACONITINE,DEHYDRO: METHYL:	ACTIVE
26	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	LYCACONITINE,DEHYDRO:	ACTIVE
27	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	CORRECTION OF STRUCTURE	LYCACONITINE,DEHYDRO:	ACTIVE
28	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	PUBERACONITINE,DEHYDRO:	ACTIVE
29	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	CORRECTION OF STRUCTURE	PUBERACONITINE,DEHYDRO:	ACTIVE
30	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CASHMIRADELPHINE,DEHYDRO:	ACTIVE
31	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	CORRECTION OF STRUCTURE	CASHMIRADELPHINE,DEHYDRO:	ACTIVE
32	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	BUNGAROTOXIN,ALPHA:	ACTIVE
33	RECEPTOR BINDING(ALPHA-BUNGAROTOXIN) INHIBITION	CORRECTION OF STRUCTURE	BUNGAROTOXIN,ALPHA:	ACTIVE

Citation 149034

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1